<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Centre for Cardiovascular Science</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/19D76DB0-C266-4018-B4C9-5E4D11F27014"><gtr:id>19D76DB0-C266-4018-B4C9-5E4D11F27014</gtr:id><gtr:firstName>Roland</gtr:firstName><gtr:otherNames>Howard</gtr:otherNames><gtr:surname>Stimson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FK010271%2F1"><gtr:id>9D65CFA1-3C57-4CF2-8CCD-F60CC6256F6D</gtr:id><gtr:title>Regulation of brown adipose tissue activity in humans by glucocorticoids</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>MR/K010271/1</gtr:grantReference><gtr:abstractText>Brown fat, also known as brown adipose tissue (BAT), is a unique tissue which functions to promote energy expenditure to raise body temperature. This type of fat has been extensively studied in small animals such as mice and is very important in these animals, as mice lacking BAT become obese. However brown fat has only recently been discovered in adult humans, and the importance of BAT and how it is controlled in humans is unclear. The current methods available to detect BAT activity in humans are inadequate, therefore this proposed project aims to build on existing tools and develop new techniques to determine the importance of BAT to energy expenditure in healthy humans. BAT biopsies will also be obtained from patients undergoing surgery and this tissue will be grown in culture dishes to investigate the important processes controlling its activation. Glucocorticoids are a type of steroid hormone which cause obesity if levels are persistently elevated. Glucocorticoids suppress energy production by brown fat in small animals, and we will use our new techniques to test whether glucocorticoids also suppress BAT activity in humans. The effect of glucocorticoids on the tissue biopsies will also be examined to discover the important pathways controlling energy expenditure in BAT. These studies will tell us whether blocking glucocorticoid action or other pathways in brown fat may increase energy expenditure in humans, and thereby treat obesity.</gtr:abstractText><gtr:technicalSummary>To assess macronutrient metabolism by human BAT, PET/CT scanning is currently the only available in vivo technique, but PET does not allow repeated measurements due to radiation exposure and only measures glucose uptake. We aim to measure cold-induced BAT lipid and glucose metabolism in healthy humans using three alternative techniques during stable isotope tracer infusion: 1) intra-adipose microdialysis and 2) selective venous cannulation of BAT (for arterio-interstitial and arterio-venous differences, respectively, in glucose/lipid uptake and energy production); and 3) 13C-magnetic resonance spectroscopy to measure TCA cycle activity. These in vivo techniques will be used to investigate the regulation of human BAT activity by glucocorticoids, which are potent suppressors of BAT in rodents. In parallel, we will use a protocol that we have established for primary culture of human brown adipocytes (obtained from patients undergoing elective neck surgery) to investigate glucocorticoid-sensitive pathways mediating effects on macronutrient metabolism and the role of local glucocorticoid regeneration by 11beta-hydroxysteroid dehydrogenase type 1. If successful, these tools will be vital to dissect BAT metabolic activity in human obesity, its control by other putative regulators, and the key transcription factors controlling differentiation, and to prove the concept that inhibiting glucocorticoid action increases BAT activity in humans.</gtr:technicalSummary><gtr:potentialImpactText>Firstly, as stated in the academic beneficiaries, the results from this work will help advance the understanding of the importance and regulation of brown adipose tissue in humans. This will be of benefit to researchers from around the world, as one of the major barriers to developing activators of brown adipose tissue in humans is the unknown contribution of this tissue to whole body energy expenditure. We will utilise cutting edge techniques to investigate a field which has been technologically very challenging, and these tools once created can be used by other researchers/ individuals to dissect in vivo brown adipose tissue physiology.

The private sector will also benefit from this research, namely the pharmaceutical industry. Obesity is considered to be one of the greatest threats to health in the 21st century and research into drug therapies has mainly focused on increasing satiety (decreasing energy input) rather than promoting energy expenditure, and this research will highlight the potential of this alternative strategy. This research may also highlight new candidate pathways in brown adipose tisse which industry may be interested in targeting new drug development. This may lead to collaborations between academia and industry which is critical to improved health outcomes.

Research charities and the government will also benefit from research being performed in this field. A recent call to tackle obesity as one of the major health problems in the UK has highlighted the need for further work in this field. Therefore, being seen to fund research into obesity, which will be performed in the UK, will highlight that we are serious as a nation about exploring novel approaches to tackle this major health burden.

Beneficial effects of this fellowship to the wider population will take much longer to achieve than the duration of this 4-year fellowship. However, if the results from this body of work can either directly lead to new treatments or alternatively stimulate other researchers/ industry to create new drugs to treat obesity, this would be a major improvement for the nation's health as a whole.

Finally, the applicant and technician will benefit hugely from this work. Not only will this secure employment for both individuals for a significant 4-year period, the results generated from this fellowship will place the applicant in a strong position to secure a senior fellowship. In addition, the publications and impact from this work will form the foundation for further research which allow the applicant to expand his research team, providing additional employment and training for others (e.g. PhD students, post-doctoral staff) which can benefit the country as a whole.</gtr:potentialImpactText><gtr:fund><gtr:end>2018-02-28</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-03-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1136219</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Cardiovascular Science</gtr:department><gtr:description>Collaboration with Dave Newby/ Marc Dweck</gtr:description><gtr:id>92C674D9-8B70-4FA2-A7B1-222C06738455</gtr:id><gtr:impact>We have obtained pilot funding to test whether glucocorticoids can aid in the diagnosis of unstable coronary artery disease, involving .</gtr:impact><gtr:outcomeId>56dcbb82908442.10828625-1</gtr:outcomeId><gtr:partnerContribution>They have brought their expertise in cardiac PET/CT imaging to help us determine whether glucocorticoids may aid in the diagnosis of unstable coronary artery disease.</gtr:partnerContribution><gtr:piContribution>We have generated data determining that glucocorticoids regulate myocardial metabolism in both humans and in mice.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Sarah Walmsley</gtr:description><gtr:id>30C6CE05-101B-4283-8417-3D037395A0B4</gtr:id><gtr:impact>Publication in Science Immunology DOI: 10.1126/sciimmunol.aal2861</gtr:impact><gtr:outcomeId>58b0b976a10733.11514206-1</gtr:outcomeId><gtr:partnerContribution>They have generated a HIF-1alpha knockout mouse and looked at metabolic health in the presence of infection, hypoxia and hypoxic pre-conditioning.</gtr:partnerContribution><gtr:piContribution>We have aided Sarah's group in understanding the metabolic phenotype of her mouse, designing experiments to determine effect of hypoxia on adipose tissue function and thermogenesis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Genetics &amp; Molecular Medicine</gtr:department><gtr:description>Collaboration with Nick Hastie/ You-Ying</gtr:description><gtr:id>F4A03A8F-CE6C-4E49-8C5C-172B63AAD4EA</gtr:id><gtr:impact>Original research article published in Nature Cell Biology in 2014. Further research is planned with Dr Chau to explore this in more detail, this is dependent on obtaining funding (Dr Stimson down as collaborator on her grant application).</gtr:impact><gtr:outcomeId>ZdaurS5Abtq-1</gtr:outcomeId><gtr:partnerContribution>Collaborators performed the experiments with this tissue we provided</gtr:partnerContribution><gtr:piContribution>We obtained and provided samples of human brown adipose tissue to determine the developmental origins of these cells</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Centre for Cardiovascular Science</gtr:department><gtr:description>Collaboration with Brian Walker reagarding ABCC1 transport of glucocorticoids</gtr:description><gtr:id>2B783E32-11B0-4410-AE8F-C383BC37C3D6</gtr:id><gtr:impact>Paper published in Science Translational Medicine (Nixon et al, 2016).

Funding from the International Fund for the treatment of Congenital Adrenal Hyperplasia (IFCAH) and MRC Confidence in Concept scheme obtained to determine whether corticosterone is a novel treatment for this condition.</gtr:impact><gtr:outcomeId>56dcb588bdf378.17298462-1</gtr:outcomeId><gtr:partnerContribution>They have looked at the effect of inhibiting or knocking out ABCC1 transporter in mice to determine that this transporter exports corticosterone but not cortisol to show how ABCC1 protects adipose tissue from the adverse metabolic effects of corticosterone.</gtr:partnerContribution><gtr:piContribution>We have obtained subcutaneous and visceral adipose tissue and paired plasma samples from humans to determine the levels of cortisol and corticosterone in these samples and relative expression of ABCC1 transporter in adipose tissue in humans.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Will Cawthrone for marrow adipose tissue research</gtr:description><gtr:id>08645AF7-E914-4BD8-BF8F-E61222F6F80E</gtr:id><gtr:impact>Nil to date, collaboration just commenced</gtr:impact><gtr:outcomeId>545a2f4b7454e4.04899442-1</gtr:outcomeId><gtr:partnerContribution>Our collaborator is determining the importance of bone marrow adipose tissue in rodents and determining the differences between this and other adipose tissue depots.</gtr:partnerContribution><gtr:piContribution>We are providing human marrow adipose tissue and other human adipose depots for our collaborator to determine if key differences between depots are maintained across species.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physics</gtr:department><gtr:description>Collaboration with Fredrik Karpe</gtr:description><gtr:id>C34D74F7-70A5-46CA-ADFF-95C497335723</gtr:id><gtr:impact>Original research article in preparation.

Oral communication at Keystone Meeting 2017 on Adipocyte Biology.</gtr:impact><gtr:outcomeId>58b0bc745d5bf7.88060487-1</gtr:outcomeId><gtr:partnerContribution>Provided valuable insight and training into adipose tissue vein cannulations and use of xenon to measure adipose tissue blood flow.</gtr:partnerContribution><gtr:piContribution>Developed microdialysis as a novel technique to measure in vivo brown adipose tissue activity.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Report on our research to CAH patient group</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>26E78720-A1DE-41A3-9686-0A88F2AEF9CA</gtr:id><gtr:impact>I wrote a piece on our research about a potential new treatment for congenital adrenal hyperplasia after discussing this with the head of the patient group. This was to make the community aware of the potential new treatment, the need for ongoing research to determine whether this is better than current practice, and to get valuable advice from this patient cohort about the important outcomes for us to monitor to determine the success of the treatment such as efficacy and side effects.</gtr:impact><gtr:outcomeId>58b0c274008ad4.52724852</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Patients, carers and/or patient groups</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>How and when to apply for an intermediate fellowship</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>75CFD532-BCD1-40F3-984C-30A4088A9B88</gtr:id><gtr:impact>The Young Diabetologists form Research Day is an annual event aimed at junior clinicians with an interest in Endocrinology which aims to spark interest in research and provide them with the practical information on how to undertake a period of research and pursue a research career thereafter. As a new MRC Clinician Scientist I was asked to give a lecture about my research career and top tips on how to obtain a research fellowship, and spent the day with this group to answer questions and offer advice on how to obtain an PhD and further funding.

I have met several of these young clinicians again at a recent conference and some have already set up plans for a period of research (either undertaking a PhD or MD) which is encouraging.</gtr:impact><gtr:outcomeId>iLPxHMgKR5Z</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Invited speaker at Career Development Workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>FF0B901C-CDF2-4A4D-AD6B-C592DAE800E1</gtr:id><gtr:impact>Due to my MRC Clinician Scientist award, I was asked to attend the Career Development Workshop run by the Society for Endocrinology to talk about how to further your career during and post-PhD to try and obtain independence and set up your own research team. This was attended by approximately 15 PhD and early post-doctoral scientists/ clinicians.</gtr:impact><gtr:outcomeId>56ddfe265e76b9.34474296</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:url>https://www.endocrinology.org/meetings/2016/cdw2016/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>19988</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Edinburgh and Lothians Health Foundation</gtr:description><gtr:end>2017-04-02</gtr:end><gtr:fundingOrg>Edinburgh &amp; Lothians Health Foundation</gtr:fundingOrg><gtr:id>A86183D8-45EF-4D30-B6B2-7C503655FA9D</gtr:id><gtr:outcomeId>56ddfc3aafd740.08798999</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>90000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Confidence in Concept scheme</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>DB01A761-6B46-43F7-8192-88D054DD6017</gtr:id><gtr:outcomeId>58b0be91d3c6b3.67475040</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>62691</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Edinburgh and Lothians Health Foundation Diabetes REsearch Fund</gtr:description><gtr:end>2017-11-02</gtr:end><gtr:fundingOrg>Edinburgh &amp; Lothians Health Foundation</gtr:fundingOrg><gtr:id>44B665A3-6E7F-4CCF-9397-C8ED1E5DBCD8</gtr:id><gtr:outcomeId>58b0bfff936d61.48779125</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>13200</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Heart foundation Centre of Research Excellence Award</gtr:description><gtr:end>2017-11-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>A4DC2DB8-DB90-4A1D-B2CE-B844D3BCB532</gtr:id><gtr:outcomeId>58b0bf4d9d8790.33916970</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50650</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Institutional Strategic Support Fund</gtr:department><gtr:description>Wellcome Trust Institutional Strategic Support Fund</gtr:description><gtr:end>2016-01-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>9699C985-F8C2-4C88-A4C3-26F035D4441E</gtr:id><gtr:outcomeId>56dcbc8fbd5c06.34141597</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>60000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Call for projects for IFCAH</gtr:description><gtr:end>2017-03-02</gtr:end><gtr:fundingOrg>International Fund raising for Congenital Adrenal Hyperplasia (IFCAH)</gtr:fundingOrg><gtr:id>F1233890-82D6-4DE4-8A91-612A576847CA</gtr:id><gtr:outcomeId>56ddfb136abe99.25201590</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2016-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Reduction in radiation dosage for CT-guided biopsies locally</gtr:description><gtr:geographicReach>Local/Municipal/Regional</gtr:geographicReach><gtr:id>C5A89F88-DD98-4DC3-AB08-977DD963F692</gtr:id><gtr:outcomeId>LSnyuxLQN2W</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have recently developed a novel technique to measure brown adipose tissue (BAT) activity in humans using microdialysis, following localisation of brown adipose tissue deposits using PET/CT. Insertion of these catheters into supraclavicular brown adipose tissue has not been performed previously, and we have recently presented this data (oral presentation at Keystone symposium in Keystone, Colorado Jan 2017). We have used this technique to discover new information into BAT function during warm and cold conditions, to determine substrate utilisation by BAT. This technique can be used by other groups in order to better understand BAT function.</gtr:description><gtr:id>A58D5284-6179-4352-980B-1A3BDFD565EA</gtr:id><gtr:impact>This technique has highlighted crucial new understanding of BAT physiology in humans and provides the only technique to directly assess tissue levels in vivo.</gtr:impact><gtr:outcomeId>56ddffe97ceb12.48196627</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Microdialysis measurement of in vivo brown adipose tissue activity in humans</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have developed a novel primary culture system of human brown pre-adipocytes for study of the regulation of human brown adipose tissue.</gtr:description><gtr:id>B052930F-D7EC-42EE-A743-F00813C634F4</gtr:id><gtr:impact>We have used this technique to determine the mechanisms of how glucocorticoids regulate brown adipose tissue activity in humans and determine species-specific differences in the regulation of brown adipose tissue function. This paper is currently under revision at Cell Metabolism.</gtr:impact><gtr:outcomeId>56de00a2503f89.43318422</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Culture of in vivo human brown adipocytes</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>I have set up an adipose tissue bank to provide a valuable resource. This bank comprises adipose tissue from several depots (e.g. subcutaneous, visceral, brown adipose tissue) from a variety of subjects, which can be used by local and European collaborators to answer important questions. In addition, we collect anthropometric data, genetic information and plasma samples from subjects to maximise the benefit of this resource.</gtr:description><gtr:id>EE8B82FF-94D9-480B-A19D-E3A4EFFC2FF6</gtr:id><gtr:impact>This bank forms the basis for my own research developing human brown adipocyte cultures, a primary aim of my MRC award. In addition, the bank has recently been used to help determine the lineage of different adipose tissue depots (Chau et al, Nature Cell Biology 2014), and recently to determine the presence of depot-specific transporters which regulate tissue glucocorticoid levels which may prove important for novel treatments for glucocorticoid replacement (Nixon et al, currently under revision at Science Translational Medicine).</gtr:impact><gtr:outcomeId>ifqkSpY6ayQ</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Edinburgh Adipose Tissue Bank</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7D7B3D2F-316E-4B6A-B100-B834BF95EA6C</gtr:id><gtr:title>Metformin increases in vivo 11beta-hydroxysteroid dehydrogenase type 1 activity in obese men with and without type 2 diabetes mellitus</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dc8ef21f0961802d2550131c449cb3d"><gtr:id>3dc8ef21f0961802d2550131c449cb3d</gtr:id><gtr:otherNames>Anderson AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56d8c947afaf07.92341639</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D68B02A5-CA72-41D5-AB32-1773E3A2B22F</gtr:id><gtr:title>Glucocorticoids decrease UCP-1 in human primary brown adipocytes</gtr:title><gtr:parentPublicationTitle>Adipocyte Biology, Keystone symposium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e2a715cebf97c957ff58080151332b0"><gtr:id>4e2a715cebf97c957ff58080151332b0</gtr:id><gtr:otherNames>Stimson, Roland</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>hDvEERccxe3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AEEA95E-A90F-46C7-8E02-C8079835B46F</gtr:id><gtr:title>Metformin Increases Cortisol Regeneration by 11?HSD1 in Obese Men With and Without Type 2 Diabetes Mellitus.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3dc8ef21f0961802d2550131c449cb3d"><gtr:id>3dc8ef21f0961802d2550131c449cb3d</gtr:id><gtr:otherNames>Anderson AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>588b7055981262.18095874</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>361B5716-3FAB-43DE-82A6-BA2408CB2573</gtr:id><gtr:title>Carbonyl reductase 1 catalyzes 20?-reduction of glucocorticoids, modulating receptor activation and metabolic complications of obesity.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f0d4226567f3ec085aeb18d9d88783c"><gtr:id>1f0d4226567f3ec085aeb18d9d88783c</gtr:id><gtr:otherNames>Morgan RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a8b541a328743.19689094</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E37374B7-0CFF-4C35-9EF8-7BABD3F80354</gtr:id><gtr:title>Hypoxia determines survival outcomes of bacterial infection through HIF-1alpha dependent re-programming of leukocyte metabolism.</gtr:title><gtr:parentPublicationTitle>Science immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a59e42e9d22616597037c27e2e8b3dbf"><gtr:id>a59e42e9d22616597037c27e2e8b3dbf</gtr:id><gtr:otherNames>Thompson AA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2470-9468</gtr:issn><gtr:outcomeId>58b0b546a1ea29.24504993</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFE49908-D42E-4AFC-B30B-59DC22066B78</gtr:id><gtr:title>Glucocorticoids Acutely Increase Brown Adipose Tissue Activity in Humans, Revealing Species-Specific Differences in UCP-1 Regulation.</gtr:title><gtr:parentPublicationTitle>Cell metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f423a1c922466097a33bfc54c98b5ae4"><gtr:id>f423a1c922466097a33bfc54c98b5ae4</gtr:id><gtr:otherNames>Ramage LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1550-4131</gtr:issn><gtr:outcomeId>585d700283df09.38715331</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D2231A61-FDD9-4B9F-8A24-8453BF5CE3C9</gtr:id><gtr:title>Glucocorticoids increase brown adipose tissue activity in humans, revealing species-specific differences in UCP-1 regulation</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f423a1c922466097a33bfc54c98b5ae4"><gtr:id>f423a1c922466097a33bfc54c98b5ae4</gtr:id><gtr:otherNames>Ramage LE</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>56dcade48062c8.23657802</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FE183EFB-C16D-46FE-9928-A58D7681206F</gtr:id><gtr:title>ABCC1 confers tissue-specific sensitivity to cortisol versus corticosterone: A rationale for safer glucocorticoid replacement therapy.</gtr:title><gtr:parentPublicationTitle>Science translational medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/655ab64579bcd5eeb9c643d543d5d34f"><gtr:id>655ab64579bcd5eeb9c643d543d5d34f</gtr:id><gtr:otherNames>Nixon M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1946-6234</gtr:issn><gtr:outcomeId>58b0b473607e99.38128900</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39122ADE-9BCF-4B51-9A66-E8D6308D4568</gtr:id><gtr:title>Direct measurement of in vivo substrate utilisation by human brown adipose tissue using microdialysis</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9542d54d60ada5df3b17e2dea87f208"><gtr:id>d9542d54d60ada5df3b17e2dea87f208</gtr:id><gtr:otherNames>Weir G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>58b41db0a85da1.63235971</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6E64C4F-8D09-46CF-90C8-F30560D15820</gtr:id><gtr:title>Acute interaction between hydrocortisone and insulin alters the plasma metabolome in humans.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24112c1d36bef0a01ac7eefc8682aba8"><gtr:id>24112c1d36bef0a01ac7eefc8682aba8</gtr:id><gtr:otherNames>Alwashih MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a8b531a0e4e31.82834004</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6914BCC-761D-401F-9F3B-1CC2756780DB</gtr:id><gtr:title>Acute physiological effects of glucocorticoids on fuel metabolism in humans are permissive but not direct.</gtr:title><gtr:parentPublicationTitle>Diabetes, obesity &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f6d9141015930cdcd11acdb7fe06e9c"><gtr:id>5f6d9141015930cdcd11acdb7fe06e9c</gtr:id><gtr:otherNames>Stimson RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1462-8902</gtr:issn><gtr:outcomeId>58b0b4ca75a414.91264276</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A8BB512E-3A62-4E49-B39E-B9A44DC8C898</gtr:id><gtr:title>Plasma metabolomic profile varies with glucocorticoid dose in patients with congenital adrenal hyperplasia.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/24112c1d36bef0a01ac7eefc8682aba8"><gtr:id>24112c1d36bef0a01ac7eefc8682aba8</gtr:id><gtr:otherNames>Alwashih MA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5a6366701b4204.81702610</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E00E5FB-853C-4F0A-ADBD-3879CA630F7F</gtr:id><gtr:title>Glucocorticoids acutely increase brown adipose tissue activity in humans</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6e896a509596988bb7f57315a1acc52d"><gtr:id>6e896a509596988bb7f57315a1acc52d</gtr:id><gtr:otherNames>Akyol M</gtr:otherNames></gtr:author></gtr:authors><gtr:outcomeId>56d8cbbd309a48.80078413</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0646032A-6D3B-45B1-8120-9457CCAFEE40</gtr:id><gtr:title>Glucocorticoids Increase Glucose Uptake By Human Brown Adipose Tissue in Vivo but Decrease Oxidative Phosphorylation and Inhibit Uncoupling Protein 1</gtr:title><gtr:parentPublicationTitle>Endocrine Reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5f6d9141015930cdcd11acdb7fe06e9c"><gtr:id>5f6d9141015930cdcd11acdb7fe06e9c</gtr:id><gtr:otherNames>Stimson RH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:outcomeId>542f15bbdc08b3.64030475</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE1F0A47-1988-492B-8A35-A0D783BDCF7C</gtr:id><gtr:title>Visceral and subcutaneous fat have different origins and evidence supports a mesothelial source.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e5e0b8b41e59b2ff20ed2799fddfb84"><gtr:id>7e5e0b8b41e59b2ff20ed2799fddfb84</gtr:id><gtr:otherNames>Chau YY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>542f10d4ca19d8.96794640</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K010271/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>